HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Del Labs

This article was originally published in The Tan Sheet

Executive Summary

Orajel and cosmetics drove up net sales 20.2% to $77.7 mil. for the third quarter, company says Oct. 26. Net income for the quarter was $1.2 mil., compared to a $6.1 mil. loss in the year-ago period. Nine-month sales totaled $221.7 mil., a 12.6% increase from the prior-year period. Ads for Orajel Ultra Mouth Sore Medicine, which shipped at the end of the quarter, are slated for February 2001 (1"The Tan Sheet" Oct. 9, p. 5)

You may also be interested in...



Orajel Ultra Mouth Sore "Film-Forming Gel" TV Ads Slated For February

Del Pharmaceuticals Orajel Ultra Mouth Sore Medicine, which provides "immediate pain relief" while creating a "film-forming gel" to protect canker sores from irritation, will begin appearing on store shelves this month, the company said.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

GB150348

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel